Trio, including former Novartis exec, accused of bribery to the tune of over HK$1.5 million
November 28, 2017Manufacturing and Production, Sales and Marketing Novartis, bribery, illegal
A trio, including a former Senior Medical Representative at Novartis, have been charged over allegedly conspiring to offer and accept …
University of Virginia researchers identify new target in triple-negative breast cancer
November 28, 2017Manufacturing and Production, Research and Development University of Virginia, breast cancer, pharma, triple-negative breast cancer
Researchers at the University of Virginia claim they have discovered a new target for triple-negative breast cancer, a notoriously aggressive …
NICE refuses Eisai’s breast cancer drug in new indication
November 28, 2017Manufacturing and Production, Sales and Marketing Cancer, Eisai, Halaven, NICE, breast cancer, pharma
NICE has announced that it has rejected Eisai’s Halaven (eribulin) through draft guidance advising not to use the drug in …
Pharmafocus December edition and Pharmafile Autumn 2017 are both available now!
November 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharma, pharmafile
Pharmafocus December edition is available to read online now!
Intelligent Automation in Pharmacovigilance
November 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, pharmacovigilance, primevigilance
PrimeVigilance is pleased to announce their collaboration with the International Society of Pharmacovigilance (ISoP) on the upcoming seminar, organised by …
Regeneron forced to drop Eylea combo, advantage Novartis
November 27, 2017Manufacturing and Production, Research and Development Eylea, Novartis, Regeneron, biotech, drugs, pharma, pharmaceutical
Novartis released Phase 3 data on its leading candidate for wet age-related macular degeneration (AMD) drug and it caused a …
Recipharm equips a further three facilities for US serialisation
November 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm
Recipharm, a leading contract development and manufacturing organisation (CDMO) has equipped three more of its facilities with serialisation capabilities in …
Veeva European Commercial & Medical Summit
November 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, veeva
The Veeva European Commercial & Medical Summit will begin tomorrow, seeing more than 800 industry leaders convene at the Marriot …
The global HIV/AIDS movement
November 27, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AIDS, HIV, International HIV/AIDS Alliance
Increasingly collaborative efforts have seen the threat of HIV recede and brought hope to demographics and communities most vulnerable to …
Bayer’s $175 million pneumonia drug fails at phase 3
November 27, 2017Research and Development, Sales and Marketing Amikacin, Amikacin Inhale, Bayer, Nektar Therapeutics, pharma
Bayer has been hit by the news that its latest effort in the pneumonia space failed at the Phase 3 …
AstraZeneca continues pivot to east with Chinese collaboration
November 27, 2017Medical Communications, Sales and Marketing AstraZeneca, biotech, drugs, pharma, pharmaceutical
It’s been a rocky year for AstraZeneca, it has scored some major successes yet its year has been marred by …
Proposed cuts to National Institutes of Health could delay up to 90% of US drug approvals
November 27, 2017Research and Development, Sales and Marketing Donald Trump, FDA, NIH, National Institutes of Health, Trump, pharma
President Donald Trump’s budget proposes to cut funding to the National Institutes of Health by $7.2 billion or 21%. Researchers …
UK government unveils pharma research HQ coup
November 27, 2017Medical Communications, Sales and Marketing MSD, biotech, drugs, life sciences, pharma, pharmaceutical
The UK government’s Autumn Budget struck a gloomy note for the economy, with figures pointing towards low productivity and the …
Top Ten most popular articles on Pharmafile.com this week
November 24, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing pharma, top ten
As Friday comes round again, this week saw some of the biggest news of the year: Amsterdam is the new …
Different gene mutations in multiple myeloma depending on ancestry
November 24, 2017Medical Communications, Research and Development biotech, drugs, multiple myeloma, pharma, pharmaceutical
Researchers, based in the US, have conducted a large-scale collection of publicly available data and found that significant differences can …
Ex-Pharmacy Compliance Director pleads guilty to introducing illegal drugs into the market
November 24, 2017Medical Communications Department of Justice, FDA, pharma
Caprice Bearden, a 63-year old ex-Director of Compliance for an Indiana-based Pharmakon, has been found guilty of introducing adulterated drugs …
AZ partners with Combinations Alliance to test drug in cancer
November 24, 2017Medical Communications, Research and Development AstraZeneca, biotech, drugs, pharma, pharmaceutical
A clinical trial is to be launched to test AstraZeneca’s experimental drug, AZD1775, for the treatment of head and neck …
Avatar therapy holds potential as adjunct therapy for schizophrenia
November 24, 2017Medical Communications biotech, drugs, pharma, pharmaceutical, schizophrenia
Experts have developed a new form of therapy for patients living with schizophrenia, by allowing those individuals to speak to …
Drinking three cups of coffee found to hold health benefits
November 23, 2017Medical Communications biotech, coffee, drugs, pharma, pharmaceutical
In good news for coffee drinkers, drinking three to four cups of coffee was found to lower the risk of …
Learning lessons from HIV to change the treatment access landscape
November 23, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, HIV, pharma
Greg Alton, Executive Vice President of Corporate and Medical Affairs at Gilead, reveals how the rapid development and distribution of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
